Novel Anion Exchange Media for Viral Clearance Originally delivered Sep 26, 2018 Source: 3M | This webinar is sponsored by 3M and reflects their views, opinions, and insights. Attendance is free. Type: Archived WebinarLevel: Advanced Duration: 1 hour Share This Post: Preview Webinar: The need for higher performance and lower cost manufacturing processes in biologic process development is intensifying. Take this 3M sponsored webinar to explore a new, innovative solution. In this 60-minute sponsored webinar, you’ll explore novel key material and technologies being developed at 3M to dramatically simplify downstream purification processes through the Emphaze™ platform of single-use, advanced chromatography solutions. Through case studies, see how higher product purity during harvest enhances the performance of capture chromatography in ways that can significantly abridge downstream polishing while providing superior performance of expensive capture chromatography resin. Examine advanced ligand technologies in development at 3M for advanced future single-use chromatography solutions. In addition, explore next-generation cation exchange ligand candidates and the importance of not only the nature of the active ligand, but also intramolecular structures affecting its expression. Take a look at your agenda: The promise of novel key material and technologies being developed at 3M The heart of 3M’s bioprocess innovation strategy Combining novel, heterogeneous anion exchange hydrogel technology and multizone high-capacity membrane technology What the recently launched Emphaze™ AEX Hybrid Purifier could mean to your future Presenter(s): Alexei Voloshin Alexei Voloshin is the Global Application Strategy Specialist at 3M Separation and Purification Sciences Division. He is responsible for product application strategy and manages technology projects, collaborations, and alliances around the globe. Alexei brings more than 15 years of experience in bio-process development, as well as technical, operational, and business knowledge in the biotechnology space. Before joining 3M, Alexei led molecular diagnostics program at Theranos Inc. He is also a founding member of TheraOne Inc., a start-up company focused on front line cancer...Read more Checkout Checkout Do you already own this? Log In for instructions on accessing this content. Pricing Individuals AIChE Members Free AIChE Graduate Student Members Free AIChE Undergraduate Student Members Free Non-Members $0.00 Sponsored webinars bring technical information from reputable firms and suppliers to AIChE members. The content reflects the views, opinions, and recommendations of the sponsoring organization. AIChE does not warrant or represent, expressly or by implication, the correctness or accuracy of the content of the information presented. As between (1) the AIChE, the presenter and author(s) of this work, their employers, and their employers' officers and directors, and (2) the user/viewer of this work, the user/viewer accepts any legal liability or responsibility whatsoever for the consequence of its use or misuse. Contact information for attendees of this webinar, including email address, will be shared with the sponsoring firm. You will always have the opportunity to unsubscribe from email from that organization. Language: English
Alexei Voloshin Alexei Voloshin is the Global Application Strategy Specialist at 3M Separation and Purification Sciences Division. He is responsible for product application strategy and manages technology projects, collaborations, and alliances around the globe. Alexei brings more than 15 years of experience in bio-process development, as well as technical, operational, and business knowledge in the biotechnology space. Before joining 3M, Alexei led molecular diagnostics program at Theranos Inc. He is also a founding member of TheraOne Inc., a start-up company focused on front line cancer...Read more